A groundbreaking clinical study involving nearly 4,000 infants has demonstrated that acetaminophen and ibuprofen are comparably safe for administration during the first year of life. Research conducted by the University of Auckland involved randomly assigning newborns to receive either paracetamol or ibuprofen as needed for fever or pain until they turned one year old, while monitoring the incidence of eczema and bronchiolitis. Approximately 16% of infants receiving acetaminophen developed eczema compared to 15% of those given ibuprofen, with about 5% in both groups experiencing bronchiolitis—variations deemed not statistically significant by the researchers. Serious adverse effects were infrequent, with none associated with either medication. This study, published in The Lancet Child & Adolescent Health, represents the first randomized controlled trial addressing this issue, with the research team continuing to follow the children until they reach six years of age.
Disclosure:
This video contains stock footage and content created or enhanced using AI-assisted tools.
ai-generated
